Vorma Home Hero

Vor Bio
Medical Affairs

We are dedicated to advancing science to help patients living with autoimmune diseases and support clinical advancements. Our mission drives the work we do every day.

Our Latest Publications

A Phase 3 Study to Evaluate the Efficacy and Safety of Telitacicept in Patients With Generalized Myasthenia Gravis: UPSTREAM MG Trial Design Update

UPSTREAM SjD: A Global Phase 3 Study to Evaluate the Efficacy and Safety of Telitacicept in Patients With Primary Sjögren Disease

Telitacicept for Generalized Myasthenia Gravis: Depth of Response Across 48 Weeks in a Phase 3 Study Conducted in China

Have a question? Submit a Medical Information Request.